Cargando…

68. Impact of a Pharmacy-Driven Antimicrobial Time-out on Duration of Therapy in Community-Acquired Pneumonia

BACKGROUND: Community-Acquired Pneumonia (CAP) is associated with substantial antibiotic use and potential for overprescribing. Previous studies have demonstrated a reduction in antimicrobial exposure following implementation of provider-driven antimicrobial time-outs (ATOs). ATOs prompt assessment...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Amolee R, Murrey, Timothy F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2020
Materias:	Poster Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7777066/ http://dx.doi.org/10.1093/ofid/ofaa439.113

Ejemplares similares

2193. Factors Impacting the Duration of Antimicrobial Therapy for Community-Acquired Pneumonia
por: Sandhu, Avnish, et al.
Publicado: (2019)

68. Impact of Streptococcus pneumoniae Urinary Antigen Testing in Patients with Community-Acquired Pneumonia Admitted within a Large Academic Medical System
por: Greenfield, Adam, et al.
Publicado: (2021)

146. Predictors of Long Duration Antibiotic Therapy for Urinary Tract Infections and Community-Acquired Pneumonia in Pediatric Ambulatory Care Settings
por: Shah, Rohan M, et al.
Publicado: (2021)

75. Less is More: A Physician-Driven Quality Improvement Stewardship Initiative to Reduce Excessive Duration of Antibiotic Therapy in Veterans Hospitalized with Community-Acquired Pneumonia
por: Monday, Lea M, et al.
Publicado: (2020)

66. Impact of a Pharmacist-Driven Azithromycin De-escalation Protocol for Community-Acquired Pneumonia
por: Shakeraneh, Pegah, et al.
Publicado: (2020)

99. Comparison of Procalcitonin Testing to a Targeted Audit-and Feedback Strategy on Prescribed Durations of Therapy for Community-Acquired Pneumonia
por: Clark, Lauren, et al.
Publicado: (2020)

231. Impact of DRIP Score Documentation at Time of Physician Order Entry on Combination Antimicrobials in Treatment of Community Acquired Pneumonia
por: Herbin, Shelbye R, et al.
Publicado: (2020)

1646. Optimizing Antibiotic Durations of Therapy in Pediatric Community-acquired Pneumonia
por: Cook, Gregory, et al.
Publicado: (2023)

128. Development of an Analytics Dashboard to Monitor Antimicrobial Selection and Duration for Pneumonia
por: Marx, Ashley, et al.
Publicado: (2021)

130. Antimicrobial Stewardship Practices in Community Pharmacies Across the United States
por: Lee, Yuman, et al.
Publicado: (2020)

89. Construction of an Electronic Algorithm to Efficiently Target Antimicrobial Stewardship Efforts for Adults Hospitalized with Community-acquired Pneumonia
por: Lautenbach, Ebbing, et al.
Publicado: (2020)

Duration of Antimicrobial Therapy in Community Acquired Pneumonia: Less Is More
por: Pinzone, Marilia Rita, et al.
Publicado: (2014)

151. An Electronic Algorithm to Better Target Antimicrobial Stewardship Program (ASP) Efforts for Children Hospitalized with Community-Acquired Pneumonia (CAP)
por: Gerber, Jeffrey, et al.
Publicado: (2020)

1484. Microbial Etiology of Community-acquired Pneumonia in Immunocompromised Patients
por: Deshpande, Abhishek, et al.
Publicado: (2020)

1498. Etiology of Community-acquired Pneumonia in Adults: A Systematic Review
por: Shoar, Saeed, et al.
Publicado: (2020)

1317. Prevalence of Pseudomonas aeruginosa as the Causative Organism for Community Acquired Pneumonia
por: Haviland, Adam D, et al.
Publicado: (2021)

O01 Auditing the duration of antibiotic therapy for children treated as inpatients for community acquired pneumonia
por: Alexander, Emma, et al.
Publicado: (2023)

169. Development of a Real Time Electronic Algorithm to Identify Hospitalized Patients with Community-Acquired Pneumonia
por: Fabre, Valeria, et al.
Publicado: (2020)

1204. Evaluation Of An Antimicrobial Stewardship Scorecard For Hospitalized Patients With Community-Acquired Pneumonia
por: Klatt, Megan, et al.
Publicado: (2023)

164. Restriction of Antimicrobials Dispensing without Prescription on a National Level: Impact on the Overall Antimicrobial Utilization in Community Pharmacies in Saudi Arabia
por: Eljaaly, Khalid, et al.
Publicado: (2021)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

Impact of Antimicrobial Stewardship Program Guidance on the Management of Community-Acquired Pneumonia in Hospitalized Adults
por: Walsh, Thomas, et al.
Publicado: (2017)

P19 IV antimicrobial duration in practice
por: Akintimehin, Abisoye O., et al.
Publicado: (2022)

1499. Incidence of Community Acquired Pneumonia by Age and Comorbid Conditions in the Veterans Health Administration (VHA)
por: Bej, Taissa A, et al.
Publicado: (2020)

803. Risk factors associated with Clostridioides difficile infection in hospitalized patients with community-acquired pneumonia
por: Moore, William Justin, et al.
Publicado: (2020)

33. Evaluating the Safety and Effectiveness of a Non-Severe Community-Acquired Pneumonia Pharmacist Pathway
por: Sylvain, Kelly, et al.
Publicado: (2021)

Antimicrobials: community-acquired pneumonia
Publicado: (2019)

P02 Antimicrobial susceptibility of microorganisms isolated in community-acquired pneumonia in drug-dependent patients
por: Viltsaniuk, Oksana, et al.
Publicado: (2023)

42. A Pharmacist-Led Intervention to Decrease Anaerobic Coverage for Hospitalized Patients with Community-Acquired Pneumonia
por: Enzmann, Maxx O, et al.
Publicado: (2020)

1514. Mortality and Readmission in Adults during the First Year Following Hospitalization for Community-Acquired Pneumonia in the US
por: Sato, Reiko, et al.
Publicado: (2020)

1324. Identification of Local Risk Factors for P. aeruginosa in Community-acquired Pneumonia in a Veteran Population
por: Gibbons, Emily A, et al.
Publicado: (2021)

2207. Impact of an Intervention Bundle on Azithromycin Use and 5-Day Durations of Therapy for Ambulatory Pediatric Community Acquired Pneumonia
por: Weber, Matthew J, et al.
Publicado: (2023)

77. Out of Sight, Out of Mind: Impact of an Antimicrobial Stewardship Bundle on Fluoroquinolone Utilization
por: Black, Blade W, et al.
Publicado: (2020)

Community-acquired pneumonia treated on the ICU
por: Apostolidou, E, et al.
Publicado: (2006)

1844. Improving Management of Community Acquired Pneumonia through Collaborative Integrated Care in an Antimicrobial Stewardship Initiative
por: Sehu, Marjoree, et al.
Publicado: (2018)

1457. Escherichia coli Community Acquired Pneumonia
por: John, Teny Mathew, et al.
Publicado: (2018)

Antimicrobial Treatment of Community-Acquired Pneumonia
por: Restrepo, Marcos I., et al.
Publicado: (2005)

Antimicrobial therapy of community-acquired pneumonia
por: File, Thomas M., et al.
Publicado: (2004)

P33 Day 3 reviews led by pharmacy technicians—encouraging antimicrobial stewardship
por: Nazir, Shazia
Publicado: (2022)

231. Facilitating the Everyday Steward: Impact of Mandatory Antimicrobial Indication/Duration and a 48 Hour Time Out
por: Wirtz, Ann, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_mfjd1905df8jqh8l9rabj6rvap